Hébert, Jacques
Boursiquot, Jean-Nicolas
Chapdelaine, Hugo
Laramée, Benoit
Desjardins, Marylin
Gagnon, Rémi
Payette, Nancy
Lepeshkina, Oleksandra
Vincent, Matthieu
Article History
Received: 1 November 2021
Accepted: 26 November 2021
First Online: 26 March 2022
Declarations
:
: Not applicable.
: Not applicable.
: Jacques Hébert reports personal fees outside the submitted work for advisory boards and teaching from Takeda and CSL Behring. Hugo Chapdelaine declares grants outside the submitted work from Takeda, CSL Behring, Pharvaris, Dyax, Green Cross, Sanofi, Merck and Novartis. He also reports personal fees outside the submitted work from CSL Behring, Takeda and Sobi. He is also an associate review editor with Frontiers in Immunology. Benoit Laramée declares participating in advisory committees or presentations from ALK, Takeda, CSL Behring, Novartis and Pedia-Pharm. Rémi Gagnon declares being a principal investigator on HAE trials funded by BioCryst, Takeda, CSL Behring and Pharvaris. No other competing interests were declared.